Clinical Trial Update: The Prognostic Value of Biomarkers and the Effect of Tolperisone in Acute Low Back Pain and Sciatic Pain "BETA" [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating prognostic biomarkers and the effect of tolperisone in acute low back pain and sciatic pain (BETA) is active not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain

Drugs mentioned

• Tolperisone (tolperisone)

Snippet

Sponsor: Semmelweis University | Conditions: Low Back Pain | Phase 3 | Status: ACTIVE_NOT_RECRUITING